Akeega combines niraparib, a PARP inhibitor, and abiraterone acetate, a CYP17 inhibitor, into a single tablet for BRCA2-mutated mCSPC.

In this analysis, researchers aimed to determine which factors play a role in cardiovascular risk in childhood cancer survivors.

Investigators sought to determine whether alcohol intake, particularly at higher frequency or greater quantity, was consistently associated with elevated risk for cancer.

Investigators examined cervical cancer screening guideline adherence among a nationally representative commercially insured cohort in the US to identify factors and modalities associated with ...

Poherdy can be dispensed as a substitute for Perjeta without requiring a prescription change from a health care provider.

Investigators sought to determine whether a single dose of HPV vaccine would provide similar protection as two doses.

In this study, researchers aimed to determine whether ctDNA is detectable in other bodily fluids besides blood, and to characterize any ctDNA they were able to detect.

For patients with relapsed or refractory multiple myeloma, treatment with teclistamab plus daratumumab is associated with a significant PFS benefit.

Investigators compared patient-reported cancer-related cognitive impairment between pre- and postmenopausal women with breast cancer who received endocrine therapy with or without chemotherapy.

The Food and Drug Administration (FDA) has granted traditional approval to Imdelltra ® (tarlatamab-dlle) for the treatment of adults with extensive stage small cell lung cancer (ES-SCLC) with disease ...

In this study, researchers sought to determine the impact of the FDA’s Accelerated Approval pathway among patients with solid tumors.

The approval was based on data from the single-arm, open-label phase 2 KOMET-001 trial, which evaluated ziftomenib, a menin inhibitor, in adults with R/R AML with an NPM1 mutation.